lifesciencelaw.ch

 

COVID-19 vaccines: authorised

18. November 2022 – The European Commission authorised the COVID-19 vaccine VidPrevtyn Beta. The EMA’s human medicines committee (CHMP) had recommended authorising the COVID-19 vaccine VidPrevtyn Beta as a booster in adults previously vaccinated with an mRNA or adenoviral vector COVID-19 vaccine.

For more information, see here and here.